A Potential Use of a Synthetic Retinoid TAC‐101 as an Orally Active Agent That Blocks Angiogenesis in Liver Metastases of Human Stomach Cancer Cells

TAC‐101 (4‐[3,5‐bis(trimethylsilyl)benzamido]benzoic acid) is a novel, synthetic retinoid that is effective against liver metastases of human gastrointestinal cancer cells such as the human stomach carcinoma line AZ‐521 in animal models, and is currently in use in phase I cancer trials. However, the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Jpn J Cancer Res
Autors principals: Oikawa, Tsutomu, Murakami, Koji, Sano, Masaki, Shibata, Jiro, Wierzba, Konstanty, Yamada, Yuji
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2001
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5926657/
https://ncbi.nlm.nih.gov/pubmed/11714448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2001.tb02144.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars